Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome

Ultragenyx, based in Novato, California, and GeneTx Biotherapeutics, headquartered in Downers Grove, Illinois, are partnering to advance a therapy for a rare neurogenetic disorder, Angelman syndrome. Ultragenyx will also have the option to acquire GeneTx.